Today is Wednesday, Sep. 18, 2019

Department of

Department of Psychiatry and Behavioral Neuroscience

Fellowships Program

Research Mentoring

Addiction Psychiatry Fellows have available time towards their scholarly project, which can be research. Addiction Research-Medicine Fellows also have available time for a scholarly project, but have over half of their time protected for clinically-oriented research.

Fellows determine their area of interest and then are matched to practicing researchers within the department. All fellows receive formal didactic lectures on issues central to learning how to perform clinically-oriented research (ethics, IRB, statistics, etc.).

Today, UC Department of Psychiatry and the Cincinnati VAMC rank well in terms of research funding. We have particular strengths in the areas of addiction disorders, PTSD, eating disorders, and bipolar disorder. The department has one of the largest pharmaceutical research programs of any psychiatry department in the country. We have perhaps the largest NIDA Clinical Trials Node in the country as well.

Addiction Sciences Division faculty have a wealth and variety of research projects already in place and potentially available for fellow experiences:

  • Dr. Benoit: As Director of the Behavioral Assay Core in the Obesity Research Center, Dr. Benoit’s work focuses on neurobiological controls over behavior with emphases on food intake, reward and learning.
  • Dr. Brown: Serving at UC's Addiction Sciences Division
  • Dr. Chard: As Director of the PTSD divisions in both the VA and UC, Dr. Chard is an international leader in therapy approaches to PTSD. She has authored a large number of research publications.
  • Dr. Geracioti: Serving in a leadership role in the VA's Ofice of Research, Dr. Geracioti is an international leader in PTSD research, specifically cerebrospinal fluid studies of veterans. He has collaborated with Fellows on research related to PTSD and alcohol use disorder.
  • Dr. Gore has conducted research in the following areas: dimensional approaches to personality and personality disorders, posttraumatic stress disorder and substance abuse. She is presently conducting research examining psychotherapy treatment outcomes for comorbid substance abuse and posttraumatic stress disorder.
  • Dr. Gudelsky: With funding support from NIDA, Dr. Gudelsky’s group studies the determinants and consequences of MDMA (”Ecstacy”) neurotoxicity. 
  • Dr. Hemmy Asamsama: As Program Director for the HIV and Liver Disease Postdoctoral Fellowship and a VA staff Psychologist, Dr. Hemmy Asamsama examines the relationship between chronic disease management and substance use. Other interests include reducing health-care over-utilization and bridging research with clinical practice.
  • Dr. Herman: In his role as director of the Stress Neurobiology Program, Dr. Herman and colleagues (including ASD faculty member, Dr. Ulrich-Lai) examine the physiological actions of CNS stress circuits, stress hormone secretion, affective disease states and neuronal aging.
  • Dr. Hosta: A graduate of our Addiction Psychiatry Fellowship, Dr. Hosta has studied the relationship of methadone dose on treatment retention in pregnant and postpartum methadone patients.
  • Dr. Miller: Dr. Miller has successfully competed (as mentor),  together with his fellows, to earn 2 NIDA-ABAM Research in Addiction Medicine Scholar Awards. He has performed research relating to opioid overdose and naloxone, long term opioids for pain, tobacco treatment, co-morbid PTSD and alcohol use, and TBI. This has included collaboration with Fellows.
  • Dr. Norman: NIDA-funded projects conducted by Dr. Norman have focused on developing a human antibody as an immunotherapy for cocaine use disorder.
  • Dr. Plott: A graduate of our Addiction Medicine Research Fellowship and the NIDA-ABAM Research in Addiction Medicine Program, Dr. Plott performs research studying long term opioid therapy for pain and its intersection with addiction, military sexual trauma, and other issues.
  • Dr. Silvestri: Dr. Silvestri's areas of interest include psychosocial predictors of substance use, and integrating measurement-based care in the treatment of substance use disorders. His past projects have examined laboratory procedures for studying alcohol consumption, normative influences on substance use, and patient preferences in brief evidence-based psychotherapy.
  • Dr. Vorhees: NIDA-funded reserach projects being conducted by Dr. Vorhees and colleagues are investigating HPA axis mechanisms involed in learning and memory deficits induced by developmental methampheamine exposure and the effects of neonatal MDMA exposure on learning and memory.
  • Dr. Wilder: A graduate of our Addiction Psychiatry Fellowship and an additional year of fellowship research training, Dr. Wilder is also a graduate of the NIDA-ABAM Research in Addiction Medicine Scholars Program. With local and VA funding support, Dr. Wilder’s research focuses on prevention of the adverse effects of opioid use disorder, including prevention of opioid overdose and pharmacotherapy in pregnant and postpartum women. This has included collaboration with Fellows.
  • Dr. Winhusen: As leader of one of the largest NIDA Clinical Trials Nodes, Dr. Winhusen's research focuses primarily on developing new psychotherapies for cocaine, methamphetamine, and prescription opioid addiction. This has included work on pregnant substance abusing women. Dr. Winhusen has been recognized as a leader in clinical trials delivery by NIDA with the Besteman Award given by NIDA Director Nora Volkow. She has collaborated with Fellows on research relating to methadone maintenance in pregnancy as well as ADHD and addiction.
  • Dr. Woods: Although primarily known for his pioneering work in the obesity field, Dr. Woods and colleagues have also investigated the role of neuropeptides in regulating alcohol reward processing.


 Supporting research entities that may be of interest to addiction fellows include: